These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19025814)

  • 1. Epidemiology in the pharmaceutical industry.
    Roht LH; Shinaberry L; Maybury L; Liao I; Riley E; Andrews EB; Siegfried JD
    Pharmacoepidemiol Drug Saf; 2000 Mar; 9(2):139-48. PubMed ID: 19025814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
    Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
    J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of epidemiology capacity in state health departments, 2001-2006.
    Boulton ML; Lemmings J; Beck AJ
    J Public Health Manag Pract; 2009; 15(4):328-36. PubMed ID: 19525777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry-6 Pharmacia].
    Grevsen JV; Kruse E; Kruse PR
    Theriaca; 2014; (42):9-30. PubMed ID: 25816560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Job Classifications, Career Ladders, and the Applied Epidemiology Competencies to Support Recruitment, Retention, and Practice of State Health Department Epidemiologists.
    Daly ER; Arrazola J; Umble K
    J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E552-E559. PubMed ID: 34347653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges to recruitment and retention of the state health department epidemiology workforce.
    Beck AJ; Boulton ML; Lemmings J; Clayton JL
    Am J Prev Med; 2012 Jan; 42(1):76-80. PubMed ID: 22176851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staff patterns of epidemiologists in the health departments of 12 southern states.
    Woernle CH
    Public Health Rep; 1991; 106(5):583-6. PubMed ID: 1910195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologists in industry. Past achievements, unexplored opportunities, and future needs.
    Pell S
    J Occup Med; 1993 May; 35(5):485-92. PubMed ID: 8515320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand.
    Generali JA; Hogan L
    Drug Inf J; 1983; 17(3):195-204. PubMed ID: 10265096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economics in the Canadian pharmaceutical industry.
    Assiff L; Pollock MR; Manzi P; Faienza B; Menon D
    Pharmacoeconomics; 1999 Dec; 16(6):669-78. PubMed ID: 10724794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Results of Organizational Structure and Resourcing of Medical Information Services in Support of Building Departmental Strategies.
    Marasigan K; Doshi S; Fung S
    Ther Innov Regul Sci; 2020 Nov; 54(6):1269-1274. PubMed ID: 33123969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Related to Small- and Mid-Capitalization Pharmaceutical Company Success Using Stock Performance as a Surrogate.
    Ferris MJ; Sun K; Savard C; Suresh T; Mishra MV
    Cureus; 2021 Sep; 13(9):e18210. PubMed ID: 34692353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State epidemiology programs and state epidemiologists: results of a national survey.
    Gunn RA; White MC; Miller GB; Conrad JL; Tyler CW
    Public Health Rep; 1989; 104(2):170-7. PubMed ID: 2495551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equal treatment: bestowed or earned?
    Soskolne CL
    Ann Epidemiol; 1997 Oct; 7(7):434-6. PubMed ID: 9349908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-based approach to scheduling audits.
    Rönninger S; Holmes M
    PDA J Pharm Sci Technol; 2009; 63(6):575-88. PubMed ID: 20169864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.